Phase I Study of ARX788 in HER2-Positive Metastatic Breast Cancer: Safety, Pharmacokinetics, and Antitumor Activity
Larvol Clinic
Command Palette
Search for a command to run...
Archive
303 posts published so far
Safety and Preliminary Efficacy of YSCH-01 in Advanced Solid Tumors: A Phase I Trial
Larvol Clinic
Ponatinib vs Imatinib in Newly Diagnosed Ph+ ALL: Phase 3 Trial Results on MRD-Negative Remission and Safety
Larvol Clinic
Protocol for Evaluating Transdermal Oestradiol Gel in Prostate Cancer Patients
Larvol Clinic
Effects of Dose-Intensified Salvage Radiotherapy on Erectile Function in Recurrent Prostate Cancer Post-Prostatectomy
Larvol Clinic
Safety and Preliminary Efficacy of YSCH-01 (Recombinant L-IFN Adenovirus) in Advanced Solid Tumors: A Phase I Trial
Larvol Clinic
Daratumumab Enhances PFS in Transplant-Ineligible Myeloma Patients with VCD
Larvol Clinic
Sequential Sacituzumab Govitecan and Talazoparib in Metastatic Triple-Negative Breast Cancer
Larvol Clinic
Avelumab First-Line Maintenance in Advanced Urothelial Carcinoma: J-AVENUE Study
Larvol Clinic
Incidence and Resolution of Ovarian Toxicity in the Phase 3 DeFi Study of Nirogacestat for Desmoid Tumors
Larvol Clinic
Phase I Study of ARX788 in HER2-Positive Metastatic Breast Cancer: Safety and Efficacy
Larvol Clinic
Safety and Preliminary Efficacy of YSCH-01 in Advanced Solid Tumors: A Phase I Trial
Larvol Clinic
Ponatinib vs Imatinib in Newly Diagnosed Ph+ ALL: A Phase 3 Trial of MRD-Negative Remission and Safety
Larvol Clinic
Transdermal Oestradiol Gel and Exercise in Reducing ADT Side Effects: ESTRACISE Study Protocol
Larvol Clinic
Hypofractionated Radiotherapy with Temozolomide and Bevacizumab in Glioblastoma: A Phase II Trial
Larvol Clinic
Dose-Intensified Salvage Radiotherapy and Erectile Function After Prostatectomy: A Randomized Trial
Larvol Clinic
Phase 1b/3 Study of IBI351 and Cetuximab in KRAS G12C-Mutated Colorectal Cancer
Larvol Clinic
Ovarian Toxicity in Females Treated with Nirogacestat: Phase 3 DeFi Study Results
Larvol Clinic
Phase I Study of ARX788 in HER2-Positive Metastatic Breast Cancer: Safety and Efficacy
Larvol Clinic
Ponatinib vs Imatinib in Ph+ ALL: Phase 3 Trial Shows Superior Remission Rates
Larvol Clinic
Hypofractionated Radiotherapy with Temozolomide and Bevacizumab in Glioblastoma: Phase II Trial Results
Larvol Clinic
Impact of Dose-Intensified Salvage Radiotherapy on Erectile Function Post-Prostatectomy
Larvol Clinic
Phase I Study: ARX788 in HER2-Positive Metastatic Breast Cancer
Larvol Clinic
Trial: Ponatinib vs Imatinib in Ph+ ALL
Larvol Clinic
Phase IIA Trial: Transdermal Estradiol Gel and Exercise to Reduce ADT Side Effects in Prostate Cancer
Larvol Clinic